Cargando…

Amplification of Duffy binding protein-encoding gene allows Plasmodium vivax to evade host anti-DBP humoral immunity

Antigenic variation, the capacity to produce a range of variable antigens, is a well-described strategy of Plasmodium and other parasites to evade host immunity. Here, we show that gene amplification is an additional evasion mechanism used by Plasmodium vivax to escape humoral immunity targeting PvD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Popovici, Jean, Roesch, Camille, Carias, Lenore L., Khim, Nimol, Kim, Saorin, Vantaux, Amelie, Mueller, Ivo, Chitnis, Chetan E., King, Christopher L., Witkowski, Benoit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031336/ https://www.ncbi.nlm.nih.gov/pubmed/32075983 http://dx.doi.org/10.1038/s41467-020-14574-9

Ejemplares similares

Structural basis for neutralization of P. vivax by naturally-acquired human antibodies that target DBP
por: Urusova, Darya, et al.
Publicado: (2019)

Targeting a Reticulocyte Binding Protein and Duffy Binding Protein to Inhibit Reticulocyte Invasion by Plasmodium vivax
por: Gupta, Sonal, et al.
Publicado: (2018)

The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals
por: Popovici, Jean, et al.
Publicado: (2020)

Forest malaria in Cambodia: the occupational and spatial clustering of Plasmodium vivax and Plasmodium falciparum infection risk in a cross-sectional survey in Mondulkiri province, Cambodia
por: Sandfort, Mirco, et al.
Publicado: (2020)

Is the single variant form of Plasmodium vivax Duffy binding protein-II (PvDBP-II) adequate for inclusion in a PvDBP-II-based vaccine?
por: Valizadeh, Vahideh, et al.
Publicado: (2014)

Structural Analysis of the Synthetic Duffy Binding Protein (DBP) Antigen DEKnull Relevant for Plasmodium vivax Malaria Vaccine Design
por: Chen, Edwin, et al.
Publicado: (2015)

Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding protein
por: Watson, Quentin D., et al.
Publicado: (2023)

Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia
por: Roesch, Camille, et al.
Publicado: (2020)

Plasmodium vivax Liver and Blood Stages Recruit the Druggable Host Membrane Channel Aquaporin-3
por: Posfai, Dora, et al.
Publicado: (2020)

Immunogenicity of a Plasmodium vivax vaccine based on the duffy binding protein formulated using adjuvants compatible for use in humans
por: Martinez, Francisco J., et al.
Publicado: (2023)

Plasmodium vivax Invasion of Human Erythrocytes Inhibited by Antibodies Directed against the Duffy Binding Protein
por: Grimberg, Brian T, et al.
Publicado: (2007)

Glycan Masking of Plasmodium vivax Duffy Binding Protein for Probing Protein Binding Function and Vaccine Development
por: Sampath, Sowmya, et al.
Publicado: (2013)

Therapeutic and Transmission-Blocking  Efficacy of Dihydroartemisinin/Piperaquine and Chloroquine against Plasmodium vivax Malaria, Cambodia
por: Popovici, Jean, et al.
Publicado: (2018)

Choosing interventions to eliminate forest malaria: preliminary results of two operational research studies inside Cambodian forests
por: Kunkel, Amber, et al.
Publicado: (2021)

Characterization of P. vivax blood stage transcriptomes from field isolates reveals similarities among infections and complex gene isoforms
por: Kim, Adam, et al.
Publicado: (2017)

Significant Efficacy of a Single Low Dose of Primaquine Compared to Stand-Alone Artemisinin Combination Therapy in Reducing Gametocyte Carriage in Cambodian Patients with Uncomplicated Multidrug-Resistant Plasmodium falciparum Malaria
por: Vantaux, Amélie, et al.
Publicado: (2020)

Plasmodium vivax Infection in Duffy-Negative People in Africa
por: Zimmerman, Peter A.
Publicado: (2017)

Genetic diversity in two Plasmodium vivax protein ligands for reticulocyte invasion
por: Roesch, Camille, et al.
Publicado: (2018)

Preclinical Assessment of Viral Vectored and Protein Vaccines Targeting the Duffy-Binding Protein Region II of Plasmodium Vivax
por: de Cassan, Simone C., et al.
Publicado: (2015)

Naturally-acquired and Vaccine-induced Human Monoclonal Antibodies to Plasmodium vivax Duffy Binding Protein Inhibit Invasion of Plasmodium knowlesi (PvDBPOR) Transgenic Parasites
por: Watson, Quentin D., et al.
Publicado: (2023)

Whole Genome Sequencing of Field Isolates Reveals a Common Duplication of the Duffy Binding Protein Gene in Malagasy Plasmodium vivax Strains
por: Menard, Didier, et al.
Publicado: (2013)

Effects of Mefloquine Use on Plasmodium vivax Multidrug Resistance
por: Khim, Nimol, et al.
Publicado: (2014)

Molecular epidemiology of Plasmodium vivax and Plasmodium falciparum malaria among Duffy-positive and Duffy-negative populations in Ethiopia
por: Lo, Eugenia, et al.
Publicado: (2015)

Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies
por: Payne, Ruth O., et al.
Publicado: (2017)

Duffy Phenotype and Plasmodium vivax infections in Humans and Apes, Africa
por: Culleton, Richard Leighton, et al.
Publicado: (2012)

Distribution of Duffy Phenotypes among Plasmodium vivax Infections in Sudan
por: Albsheer, Musab M.A., et al.
Publicado: (2019)

Identification of Reticulocyte Binding Domain of Plasmodium ovale curtisi Duffy Binding Protein (PocDBP) Involved in Reticulocyte Invasion
por: Hoque, Mohammad Rafiul, et al.
Publicado: (2021)

Plasmodium vivax infection in Anajás, State of Pará: no differential resistance profile among Duffy-negative and Duffy-positive individuals
por: Carvalho, Tarcisio AA, et al.
Publicado: (2012)

G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients
por: Khim, Nimol, et al.
Publicado: (2013)

Reduced Plasmodium vivax Erythrocyte Infection in PNG Duffy-Negative Heterozygotes
por: Kasehagen, Laurin J., et al.
Publicado: (2007)

Vivax malaria in Mauritania includes infection of a Duffy-negative individual
por: Wurtz, Nathalie, et al.
Publicado: (2011)

Plasmodium vivax Duffy binding protein: understanding targets of protective immunity
por: Adams, John H, et al.
Publicado: (2014)

Antibody responses to Plasmodium vivax Duffy binding and Erythrocyte binding proteins predict risk of infection and are associated with protection from clinical Malaria
por: He, Wen-Qiang, et al.
Publicado: (2019)

Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1
por: Guy, Andrew J., et al.
Publicado: (2018)

Liver-stage fate determination in Plasmodium vivax parasites: Characterization of schizont growth and hypnozoite fating from patient isolates
por: Vantaux, Amélie, et al.
Publicado: (2022)

Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
por: Hou, Mimi M., et al.
Publicado: (2023)

Polymorphism patterns in Duffy-binding protein among Thai Plasmodium vivax isolates
por: Gosi, Panita, et al.
Publicado: (2008)

In vitro evaluation of the role of the Duffy blood group in erythrocyte invasion by Plasmodium vivax
Publicado: (1989)

Asymptomatic Plasmodium vivax infections among Duffy-negative population in Kedougou, Senegal
por: Niang, Makhtar, et al.
Publicado: (2018)

High frequency of the Duffy-negative genotype and absence of Plasmodium vivax infections in Ghana
por: Brown, Charles A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1i306av3l82pl38i38q0cut9f4